In Vivo Footprinting and Mutational Analysis of the Proximal CD19 Promoter Reveal Important Roles for an SP1/Egr-1 Binding Site and a Novel Site Termed the PyG Box

Journal of Immunology

Volumn 159, Issue 3, 1997, Pages 1284-1292

  Riva, Agostino ^a   Wilson, Gaye Lynn ^a   Kehrl, John H ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; DNA BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; EGR1 PROTEIN, HUMAN; IMMEDIATE EARLY PROTEIN; NUCLEAR PROTEIN; PAX5 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR SP1;

ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BINDING SITE; CELL CULTURE; CHEMISTRY; DNA BASE COMPOSITION; DNA FOOTPRINTING; GENETICS; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROMOTER REGION; REPORTER GENE; TONSIL;

ANTIGENS, CD19; B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; BASE COMPOSITION; BASE SEQUENCE; BINDING SITES; DNA FOOTPRINTING; DNA MUTATIONAL ANALYSIS; DNA-BINDING PROTEINS; EARLY GROWTH RESPONSE PROTEIN 1; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENES, REPORTER; HUMANS; IMMEDIATE-EARLY PROTEINS; LYMPHOMA, B-CELL; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); SP1 TRANSCRIPTION FACTOR; TONSIL; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0031204702     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Blackwell, T. K., and F. W. Alt. 1989. Mechanisms and developmental program of immunoglobulin gene rearrangement in mammals. Annu. Rev. Genet. 23:605.
2. Calame, K., and S. Ghosh. 1995. Regulalion of immunoglobulin transcription. In Honjo, T., F. W. Alt, and T. H. Rabbits, eds. Immunoglubulin Genes. Academic Press, London. pp. 397-422.
3. Williams, A. F., and A. N. Barclay. 1988. The immunoglobulin superfamily-domains for cell surface recognition. Annu. Rev. Immunol. 88:381.
4. Hagman, J., and R. Grosschedl. 1994. Regulation of gene expression at early stages of B cell differentiation. Curr. Opin. Immunol. 6:222.
5. Singh, H. 1994. Genetic analysis of transcription factors implicated in B lymphocyte development. Immunol. Res. 13:380.
6. Ernst, P., and S. T. Smale. 1995. Combinatorial regulation of transcription. II. The immunoglobulin μ heavy chain enhancer. Immunity 2:427.
7. Feldhaus, A. L., D. Mbangkollo, K. L. Arvin, C. A. Klug, and H. Singh. 1992. BLyF, a novel cell-type- and stage-specific regulatory of the B-lymphocyle gene mb-1. Mol. Cell. Biol. 12:1126.
8. Travis, A., J. Hagman, and R. Grosschedl. 1991. Heterogeneously initiated transcription from the pre-B- and B-cell-specific mb-1 promoter: analysis of the requirement for upstream factor-binding sites and initiate site sequences. Mol. Cell. Biol. 11:5756.
9. Omori, S. A., and R. Wall. 1993. Multiple motifs regulate the B-cell-specific promoter of the B29 gene. Proc. Natl. Acad. Sci. USA 90:11723.
10. Thompson, A. A., W. J. Wood, M. J. Gilly, M. A. Damore, S. A. Omori, and R. Wall. 1996. The promoter and 5′ flanking sequences controlling human B29 gene expression. Blood 87:666.
11. Himmelmann, A., G. L. Wilson, A. Riva, B. P. Lucas, C. Thevenin, and J. H. Kehrl. 1997. PU.1/Pip and basis helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage and stage specific expression of CD20 in B lymphocytes. Blood In press.
12. Kehrl, J. H., A. Riva, G. L. Wilson, and C. Thevenin. 1994. Molecular mechanisms regulating CD19, CD20 and CD22 gene expression. Immunol. Today 15: 432.
13. Engel, P., L. J. Zhou, D. C. Ord, S. Sato, B. Koller, and T. F. Tedder. 1995. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or over express the CD19 signal transduction molecule. Immunity 3:39.
14. Tedder, T., and C. Isaacs. 1989. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes: a new member of the immunoglobulin superfamily. J. Immunol. 143:712.
15. Zhou, L. J., H. M. Smith, T. J. Waldschmidt, T. Schwarting, J. Daley, and T. F. Tedder. 1994. Tissue-specific expression of the human CD19 gene in transgenic mice inhibits antigen-independent B-lymphocyte development. Mol. Cell. Biol. 14:3884.
16. Zhou, L. J., D. C. Ord, S. A. Omori, and T. F. Tedder. 1992. Structure of the genes encoding the CD19 antigen of human and mouse B lymphocytes. Immunogenetics 35:102.
17. Kozmik, Z., S. Wang, P. Dorfler, B. Adams, and M. Busslinger. 1992. The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell. Biol. 12:2662.
18. Adams, B., P. Dorfler, A. Aguzzi, Z. Kozmik, P. Urbanick, I. Maurer-Fogy, and M. Busslinger. 1992. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 6:1589.
19. Urbane, P., Z. Q. Wang, I. Fetka, E. F. Wagner, and M. Busslinger. 1994. Complete block of early B-cell differentiation and altered patterning of the posterior mid-brain in mice lacking Pax5/BSAP. Cell 79:901.
20. Harrison, K. A., K. M. Druey, Y. Deguchi, J. M. Tuscano, and J. H. Kehrl. 1994. A novel human homeobox gene distantly related to proboscipedia is expressed in lymphoid and pancreatic tissues. J. Biol. Chem. 269:19968.
21. Dignam, J. D., P. L. Martin, B. S. Shastry, and R. G. Roeder. 1983. Eukaryotic gene transcription with purified components. Methods Enzymol. 101:582.
22. Garraway, I. P., K. Semple, and S. T. Smale. 1996. Transcription of the lymphocyte-specific terminal deoxynucleotidyltransferase gene requires a specific core promoter structure. Proc. Natl. Acad. Sci. USA 93:4336.
23. Lo, K., N. R. Landau, and S. T. Smale. 1991. LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes. Mol. Cell. Biol. 11:5229.
24. Georgopoulos, K., D. D. Moore, and B. Derfler. 1992. Ikaros, an early lymphoid-specific transcription factor and a putative mediator for T cell commitment. Science 258:808.
25. Mueller, P. R., and B. Wold. 1991. Ligation mediated PCR for genomic sequencing and footprinting. In Ausubal, F., eds. Current Protocols in Molecular Biology. John Wiley & Sons, New York, pp. 15.5.1-15.5.16.
26. Georgopoulos, K., M. Bigby, J. H. Wang, A. Molnar, P. Wu, S. Winandy, and A. Sharpe. 1994. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79:143.
27. Himmelmann, A., C. Thevenin, K. Harrison, and J. H. Kehrl. 1996. Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SP1 sites. Blood 87:1036.
28. Herrscher, R. F., M. H. Kaplan, D. L. Lelsz, C. Das, R. Scheuermann, and P. W. Tucker. 1995. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B-cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev. 9:3067.
29. Bain, G., E. C. Maandag, D. J. Izon, D. Amsen, A. M. Kruisbeek, B. C. Weintraub, I. Krop, M. S. Schlissel, A. J. Feeney, and M. VanRoom. 1994. E2A proteins are required for proper B-cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885.
30. Zhuang, P., Soriano, and H. Weintraub. 1994. The helix-loop-helix gene E2A is required for B-cell formation. Cell 79:875.
31. Lin, H., and R. Grosschedl. 1995. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376:263.
32. Eisenbeis, C. F., H. Singh, and U. Storb. 1995. Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev. 9:1377.
33. Corcoran, L. M., M. Karvelas, G. J. Nossal, Z. S. Ye, T. Jacks, and D. Baltimore. 1993. Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev. 7:570.
34. Tuscano, J. M., K. M. Druey, A. Riva, J. Pena, C. B. Thompson, and J. H. Kehrl. 1996. Bcl-x rather than Bcl-2 mediates CD40-dependent centrocyte survival in the germinal center. J. Immunol. 88:1359.
35. Brandeis, M., D. Frank, I. Keshet, Z. Siegfried, M. Mendelsohn, A. Nemes, V. Temper, A. Razin, and H. Cedar. 1994. Sp1 elements protect a CpG island from de novo methylation. Nature 371:435.
36. Cross, S. H., and A. P. Bird. 1995. CpG islands and genes. Curr. Opin. Genet. Dev. 5:309.
37. Dusing, M. R., and D. A. Wiginton. 1994. Sp1 is essential for both enhancer-mediated and basal activation of the TATA-less human adenosine deaminase promoter. Nucleic Acids Res. 22:669.
38. Chen, H. M., H. L. Pahl, R. J. Scheibe, D. E. Zhang, and D. G. Tenen. 1993. The Sp1 transcription factor binds the CD11b promoter specifically in myeloid cells in vivo and is essential for myeloid-specific promoter activity. J. Biol. Chem. 268:8230.
39. Zhang, D. E., C. J. Hetherington, S. Tan, S. E. Dziennis, D. A. Gonzalez, H. M. Chen, and D. G. Tenen. 1994. Sp1 is a critical factor for the monocytic specific expression of human CD14. J. Biol. Chem. 269:11425.
40. Kudo, S., and M. Fukuda. 1994. Transcriptional activation of human leukosialin (CD43) gene by Sp1 through binding to a GGGTGG motif. Eur. J. Biochem. 223:319.
41. Maltzman, J. S., J. A. Carman, and J. G. Monroe. 1996. Role of EGR1 in regulation of stimulus-dependent CD44 transcription in B lymphocytes. Mol. Cell. Biol. 16:2283.